Skip to Main Navigation Skip to Main Content Skip to Footer
search play2 play3 facebook twitter linkedin2 cross instagram
ASCP
  • DASHBOARD
  • STORE
  • LOGOUT
  • STORE
  • LOGIN
Menu
  • Jobs
  • ASCP
  • User Auth Test Page
  • Combination IV Doxycycline Plus Azithromycin More Effective Than Monotherapy For Treatment Of Severe Scrub Typhus, Trial Indicates

    Healio (3/1, Feller) reports “a combination therapy of IV doxycycline and azithromycin was more effective for the treatment of severe scrub typhus than using either drug alone, according to” a “randomized controlled trial” published in The New England Jou...
    Full Article
  • Bird Flu Cases In Cambodia Show No Sign Of Human-To-Human Transmission, Health Officials Say

    The AP (3/1, Cheang) reports that “recent cases of bird flu discovered in two Cambodian villagers, one of them fatal, show no sign of human-to-human transmission, health officials in the Southeast Asian nation say.” An 11-year-old “girl from a village in...
    Full Article
  • Congenital Syphilis Rates Rising In US

    CNN (3/1, Goodman, McPhillips) reports “rates of syphilis in babies are rising at an alarming rate in the United States.” Public health experts see congenital syphilis as “a ‘never event’ – something that should never happen – because nearly every case is...
    Full Article
  • Illinois Plant Closure To Worsen Shortages Of Treatment For Children With RSV, Asthma

    The Washington Post (3/1, Rowland) reports specialists warned that “the sudden shutdown of an Illinois manufacturing plant last week...will prolong shortages of an important treatment for kids with RSV and asthma who show up in emergency rooms.” On Thursd...
    Full Article
  • Pfizer-BioNTech Seek Emergency Use Authorization Of Bivalent COVID-19 Vaccine As Booster Dose In Children Under Five Years

    Reuters (3/1, Roy) reports Pfizer and BioNTech “have applied for emergency use authorization of their Omicron-adapted COVID-19 vaccine in the United States as a booster dose for children aged six months through four years, the companies said on Wednesday....
    Full Article
  • FDA Panel Recommends Pfizer’s RSV Vaccine Candidate For Older Adults

    The AP (2/28, Perrone) reports a panel of FDA advisers “on Tuesday narrowly backed an experimental vaccine from Pfizer that could soon become the first shot to protect older adults against” RSV. The panel “voted 7-4 on two separate questions of whether Pf...
    Full Article
  • Study Finds No Correlation Between Residual CNS Immune Activation And Pretreatment Immune Status Among Patients With HIV Who Initiate ART During Chronic Infection

    Infectious Disease Advisor (2/28, Nye) reports study findings “showed no correlation between residual...central nervous system (CNS) immune activation and pretreatment immune status among patients with HIV infection who initiated antiretroviral therapy (A...
    Full Article
  • Studies Demonstrate High Adherence Levels, Acceptability Of Long-Acting, Injectable PrEP For HIV Prevention Among Varying Populations

    Healio (2/28, Feller) reports, “Two studies presented at the Conference on Retroviruses and Opportunistic Infections demonstrated high adherence levels and acceptability of long-acting, injectable PrEP for HIV prevention among varying groups of people.” O...
    Full Article
  • Tenofovir Withdrawal Should Not Be Recommended For Patients With Chronic HBV, Trial Suggests

    Gastroenterology Advisor (2/28, Nye) reports “tenofovir withdrawal should not be recommended for patients with chronic hepatitis B virus (HBV) infection, according to” results from the “Hepatitis B Research Network (HBRN) trial” published in the American...
    Full Article
  • White House Says There Is No Consensus In US Government On COVID-19 Origins

    USA Today (2/27, Morin) reports, “The White House said there isn’t a consensus across the government on the origins of COVID-19.” This “announcement comes after reporting that the U.S. Department of Energy concluded the pandemic most likely began after an...
    Full Article
  • Deforestation Raises Risk Of Ebola Outbreak In Uganda, Democratic Republic Of The Congo, Analysis Finds

    ProPublica (2/27, Younes, Kamano) reports, “Researchers considered more than 100 variables that could contribute to an Ebola outbreak and found that the ones that began in Meliandou and six other locations in Uganda and the Democratic Republic of Congo we...
    Full Article
  • Earlier Initiation Of ART May Delay HIV Viral Rebound After Treatment Interruption, Systematic Review Suggests

    Infectious Disease Advisor (2/27, Nye) reports research suggests “HIV viral rebound after treatment interruption may be delayed by initiating antiretroviral therapy (ART) in the acute or early phase of HIV infection.” The findings of the 31-study systemat...
    Full Article
  • IV Methylprednisolone Does Not Significantly Affect Length Of Hospitalization Vs IV Immunoglobulin Therapy In Children With Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2, Trial Indicates

    Infectious Disease Advisor (2/27, Barowski) reports, “Children with pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) who are treated with intravenous (IV) methylprednisolone do not have a statistically significan...
    Full Article
  • Earlier Initiation Of HPV Vaccination Improves Coverage Rates Among Teens, Study Finds

    MedPage Today (2/27, Henderson) reports, “Teenagers had better vaccine coverage against human papillomavirus (HPV) if they were vaccinated at earlier ages as older children instead of early adolescents, a retrospective study showed.” The “initiators vacci...
    Full Article
  • Federal Officials Say They Are Working To Address Backlog Of Healthcare Complaints

    The AP (2/27, Seitz) reports “federal officials said Monday they’re working to cut down on a growing backlog of complaints lodged against health care” professionals, “insurers or government agencies by patients who claim their civil rights or privacy have...
    Full Article
  • FDA Authorizes First OTC At-Home Combination Test For Flu, SARS-CoV-2

    USA Today (2/25, Snider) reported the FDA “has authorized the first over-the-counter at-home test that can detect and differentiate between a test result for flu and a test result for COVID-19.” The “Lucira COVID-19 and Flu Home Test is a single-use test,...
    Full Article
  • Researchers Develop Method For Creating Soft, Electronically Conductive Materials In Living Tissue

    HealthDay (2/24, Murez) reported, “Swedish scientists say they have grown electrodes in living tissue, paving the way for formation of fully integrated electronic circuits in living organisms.” For the study published in the journal Science, “researchers...
    Full Article
  • CDC Warns About Rise In Extensively Drug-Resistant Shigella Infections In US

    The Washington Post (2/25, Sun) reported the CDC “is warning clinicians and public health departments about a sharp rise in serious gastrointestinal infections caused by bacteria that are resistant to common antibiotics.” In a health advisory released on...
    Full Article
  • Cambodia Working To Identify H5N1 Virus After Two Confirmed Human Infections

    The New York Times (2/24, Mandavilli, Anthes) reported that “after a father and daughter were diagnosed with bird flu, officials in Cambodia scrambled to test nearly a dozen of their contacts for infection” from “the H5N1 virus, which has been causing mas...
    Full Article
  • Nasal Vaccine Provides Strong Protection Against COVID-19, Preliminary Data Show

    NBC News (2/24, Chow) reported, “An experimental nasal vaccine provided strong protection against Covid infection, according to preliminary results from a Phase 1 clinical trial” released earlier this month. The vaccine, developed by startup “Blue Lake Bi...
    Full Article
  • «
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • »
Footer
Chicago (Headquarters)
33 West Monroe Street, Suite 1600, Chicago, IL 60603

Privacy Policy 

Terms of Use

Follow Us

Copyright ©2021  by American Society for Clinical Pathology. All Rights Reserved.

Chat With BOC

close
First Name *
Last Name *
Email *
Customer ID

Request a Call from Customer Relations

Close
Name *
Topic *
Phone Number *
Scheduled Date *
Scheduled Time *
Customer Id